Literature DB >> 6311089

Ceftriaxone distribution between maternal blood and fetal blood and tissues at parturition and between blood and milk postpartum.

D A Kafetzis, D C Brater, J E Fanourgakis, J Voyatzis, P Georgakopoulos.   

Abstract

The penetration of ceftriaxone into the fetus at parturition was studied in 17 subjects. Despite its high protein binding, ceftriaxone quickly reached the umbilical cord blood, amniotic fluid, and placenta, achieving substantial concentrations, which then disappeared, with elimination half-lives of approximately 6 h, identical to that of the mother. The elimination half-life of ceftriaxone of 5 to 6 h in these mothers was somewhat shorter than that reported for normal subjects. The concentrations of ceftriaxone achieved in fetal tissues were sufficient for therapeutic effects. The penetration of ceftriaxone into milk was studied 3 days postpartum in 20 other patients. This antimicrobial agent entered breast milk rapidly and disappeared with a half-life of 12 to 17 h. The concentrations achieved were only 3 to 4% of those in maternal serum and were most likely of little clinical relevance.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6311089      PMCID: PMC184988          DOI: 10.1128/AAC.23.6.870

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  CSTRIP, a fortran IV computer program for obtaining initial polyexponential parameter estimates.

Authors:  A J Sedman; J G Wagner
Journal:  J Pharm Sci       Date:  1976-07       Impact factor: 3.534

2.  Maternal-fetal pharmacology of cefatrizine in the first 20 weeks of pregnancy.

Authors:  B Bernard; P Thielen; J Garcia-Cázares; C A Ballard
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

3.  Maternal-fetal transfer of cefazolin in the first twenty weeks of pregnancy.

Authors:  B Bernard; L Barton; M Abate; C A Ballard
Journal:  J Infect Dis       Date:  1977-09       Impact factor: 5.226

4.  Placental transfer of clindamycin and gentamicin in term pregnancy.

Authors:  A J Weinstein; R S Gibbs; M Gallagher
Journal:  Am J Obstet Gynecol       Date:  1976-04-01       Impact factor: 8.661

5.  Placental transfer of methicillin.

Authors:  M A MacAulay; W B Molloy; D Charles
Journal:  Am J Obstet Gynecol       Date:  1973-01-01       Impact factor: 8.661

6.  Transfer of cephaloridine from mother to fetus.

Authors:  L J Arthur; W L Burland
Journal:  Arch Dis Child       Date:  1969-02       Impact factor: 3.791

7.  Transfer of cefotaxime in human milk and from mother to foetus.

Authors:  D A Kafetzis; C V Lazarides; C A Siafas; P A Georgakopoulos; C J Papadatos
Journal:  J Antimicrob Chemother       Date:  1980-09       Impact factor: 5.790

8.  Materno-fetal cephradine transfer in pregnancy.

Authors:  I Craft; T C Forster
Journal:  Antimicrob Agents Chemother       Date:  1978-12       Impact factor: 5.191

Review 9.  Pharmacokinetics of antibiotics in pregnancy and labour.

Authors:  A Philipson
Journal:  Clin Pharmacokinet       Date:  1979 Jul-Aug       Impact factor: 6.447

10.  Tobramycin: maternal-fetal pharmacology.

Authors:  B Bernard; S J Garcia-Cazares; C A Ballard; L D Thrupp; A W Mathies; P F Wehrle
Journal:  Antimicrob Agents Chemother       Date:  1977-04       Impact factor: 5.191

View more
  18 in total

Review 1.  Antibiotics and breast-feeding: a critical review of the literature.

Authors:  Allison M Chung; Michael D Reed; Jeffrey L Blumer
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 2.  Pharmacokinetic changes during pregnancy and their clinical relevance.

Authors:  R Loebstein; A Lalkin; G Koren
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

3.  Evidence that antibiotic administration is effective in the treatment of a subset of patients with intra-amniotic infection/inflammation presenting with cervical insufficiency.

Authors:  Kyung Joon Oh; Roberto Romero; Jee Yoon Park; JoonHo Lee; Agustin Conde-Agudelo; Joon-Seok Hong; Bo Hyun Yoon
Journal:  Am J Obstet Gynecol       Date:  2019-03-28       Impact factor: 8.661

4.  Antibiotic administration can eradicate intra-amniotic infection or intra-amniotic inflammation in a subset of patients with preterm labor and intact membranes.

Authors:  Bo Hyun Yoon; Roberto Romero; Jee Yoon Park; Kyung Joon Oh; JoonHo Lee; Agustin Conde-Agudelo; Joon-Seok Hong
Journal:  Am J Obstet Gynecol       Date:  2019-03-27       Impact factor: 8.661

5.  Prediction of drug distribution into human milk from physicochemical characteristics.

Authors:  H C Atkinson; E J Begg
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

Review 6.  Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections.

Authors:  Harriet M Lamb; Douglas Ormrod; Lesley J Scott; David P Figgitt
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 7.  Cephalosporins in urinary tract infection.

Authors:  L O Gentry
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 8.  Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  D M Richards; R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-06       Impact factor: 9.546

9.  Ceftriaxone in the treatment of chronic donovanosis in central Australia.

Authors:  A Merianos; M Gilles; J Chuah
Journal:  Genitourin Med       Date:  1994-04

10.  Pharmacokinetics and protein binding of ceftriaxone during pregnancy.

Authors:  P Bourget; H Fernandez; V Quinquis; C Delouis
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.